Market Cap 10.60M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 9,200
Avg Vol 32,806
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 15%
Beta 0.90
Analysts Hold
Price Target $20.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
mmqwerty00
mmqwerty00 Aug. 3 at 2:02 AM
$STRO $KZR $BOLT Can learn a valuable lesson in microcap bio world...sometimes don't fall for the "trading at 30% of cash" line. Can't count the times I've fallen over myself at the old trading to a discount of cash reason to buy a stock...and get burned. Competent management is a heck of a lot more important!
0 · Reply
Stmkr
Stmkr Aug. 2 at 10:53 AM
$BOLT Fair point. Investing based on announced plans of partnerships is rarely a good idea. But sometimes it happens. In the case of BOLT: - trading much below cash. No debts. No warrants. Very small float - potential partnership for one asset by the end of 2025 (sure, may never happen) - potential new partnership for the platform - already 2 ongoing partnerships (Genmab + Toray) - ph1 data from wholy owned next-gen asset within cash runway So many shots on goal. We need just 1 win for a huge spike.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 1 at 4:48 PM
$BOLT Never invest for partnerships. Biotech investing 101. $BCAB had "term sheets" and also promised multiple deals. Guess what nothing ever happened. This will be 50% lower by December.
1 · Reply
BiotechValues
BiotechValues Aug. 1 at 3:49 PM
$BOLT non-binding term sheets were due in early June. Next update on deal discussions should be in 2 weeks in conjunction with earnings. Remember, company has guided to getting a deal done "by fall"
0 · Reply
StockTwitsGhost
StockTwitsGhost Jul. 31 at 4:49 PM
$BOLT Congrats to those who shorted BOLT at $10. Cash runway is limited, Dilution coming . IMO don’t cover until <$2. BOLT CFO came from Sunesis and Sunesis didn’t end well for shareholders. Just my opinion, remember to always conduct your own due dilligence. https://www.sec.gov/Archives/edgar/data/1641281/000095017025043900/2025_s-8_evergreen.htm
2 · Reply
SDBiotechInvestor
SDBiotechInvestor Jul. 31 at 3:30 PM
$BOLT - no data until 2026. This will bleed all year...
1 · Reply
Stmkr
Stmkr Jul. 31 at 9:37 AM
$BOLT pretty interesting. Cash balance of $58.0 million as of March 31, 2025 anticipated to fund key milestones through mid-2026. vs market cap $11M. Small float after RS. One post-ph1 asset looking to partner by end of 2025. One wholy owned asset with ph1 data within cash runway. Genmab collab for up to 3 assets (so far working on 2) + another collab with Toray. What's the catch??
0 · Reply
Drugtrade
Drugtrade Jul. 30 at 4:26 PM
$BOLT do somethin already
1 · Reply
SugarPumping
SugarPumping Jul. 30 at 3:15 PM
$BOLT disgusting moves, its gonna give a new low
0 · Reply
BiotechValues
BiotechValues Jul. 28 at 8:27 PM
$BOLT Another example of the thesis. Similar nano float/nano market cap/left for dead $AIM spiked to $35 in pre-market on a PR, after trading at $7. They only have $6M in cash vs $BOLT's $58M and have no Tang involvement. It's going to happen someday, and I intend to be there ;)
1 · Reply
Latest News on BOLT
Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 11 months ago

Bolt Biotherapeutics Announces Changes to its Board of Directors


mmqwerty00
mmqwerty00 Aug. 3 at 2:02 AM
$STRO $KZR $BOLT Can learn a valuable lesson in microcap bio world...sometimes don't fall for the "trading at 30% of cash" line. Can't count the times I've fallen over myself at the old trading to a discount of cash reason to buy a stock...and get burned. Competent management is a heck of a lot more important!
0 · Reply
Stmkr
Stmkr Aug. 2 at 10:53 AM
$BOLT Fair point. Investing based on announced plans of partnerships is rarely a good idea. But sometimes it happens. In the case of BOLT: - trading much below cash. No debts. No warrants. Very small float - potential partnership for one asset by the end of 2025 (sure, may never happen) - potential new partnership for the platform - already 2 ongoing partnerships (Genmab + Toray) - ph1 data from wholy owned next-gen asset within cash runway So many shots on goal. We need just 1 win for a huge spike.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 1 at 4:48 PM
$BOLT Never invest for partnerships. Biotech investing 101. $BCAB had "term sheets" and also promised multiple deals. Guess what nothing ever happened. This will be 50% lower by December.
1 · Reply
BiotechValues
BiotechValues Aug. 1 at 3:49 PM
$BOLT non-binding term sheets were due in early June. Next update on deal discussions should be in 2 weeks in conjunction with earnings. Remember, company has guided to getting a deal done "by fall"
0 · Reply
StockTwitsGhost
StockTwitsGhost Jul. 31 at 4:49 PM
$BOLT Congrats to those who shorted BOLT at $10. Cash runway is limited, Dilution coming . IMO don’t cover until <$2. BOLT CFO came from Sunesis and Sunesis didn’t end well for shareholders. Just my opinion, remember to always conduct your own due dilligence. https://www.sec.gov/Archives/edgar/data/1641281/000095017025043900/2025_s-8_evergreen.htm
2 · Reply
SDBiotechInvestor
SDBiotechInvestor Jul. 31 at 3:30 PM
$BOLT - no data until 2026. This will bleed all year...
1 · Reply
Stmkr
Stmkr Jul. 31 at 9:37 AM
$BOLT pretty interesting. Cash balance of $58.0 million as of March 31, 2025 anticipated to fund key milestones through mid-2026. vs market cap $11M. Small float after RS. One post-ph1 asset looking to partner by end of 2025. One wholy owned asset with ph1 data within cash runway. Genmab collab for up to 3 assets (so far working on 2) + another collab with Toray. What's the catch??
0 · Reply
Drugtrade
Drugtrade Jul. 30 at 4:26 PM
$BOLT do somethin already
1 · Reply
SugarPumping
SugarPumping Jul. 30 at 3:15 PM
$BOLT disgusting moves, its gonna give a new low
0 · Reply
BiotechValues
BiotechValues Jul. 28 at 8:27 PM
$BOLT Another example of the thesis. Similar nano float/nano market cap/left for dead $AIM spiked to $35 in pre-market on a PR, after trading at $7. They only have $6M in cash vs $BOLT's $58M and have no Tang involvement. It's going to happen someday, and I intend to be there ;)
1 · Reply
BiotechValues
BiotechValues Jul. 25 at 10:14 PM
$BOLT Surprised no one realizes Tang is here. They own 10% and are the largest holder. Stock is $6 with $30/share in cash and ~$1B in potential milestones from Genmab. With a float of under 1M shares either a Tang Bang will occur on news or Tang will buy for cash value. Win/win
1 · Reply
Drugtrade
Drugtrade Jul. 23 at 8:08 PM
$MRSN $BOLT $ANRO $LIMN all green yet cant hold a gain as usual, might change soon added to bolt, limn today the other i have too much already. Good luck no chance they all tank to zero right?
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 23 at 3:56 PM
$BOLT PT 7 multi day.
0 · Reply
BiotechValues
BiotechValues Jul. 22 at 7:25 PM
$BOLT - if you have X, here is a thread of why I think the stock is a great buy here: https://x.com/BioValues/status/1947739034522161588
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 18 at 10:30 AM
$BOLT remember 5.74* is the only thing that matters on your chart moving forward for now ! as u loop
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 18 at 10:29 AM
$BZAI leavign something on 5.68 to the $BOLT folks
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 18 at 12:37 AM
$BOLT i completely altered the 5.74 on your grid 2 have both options so mark that 5.74 down ASAP on your charts if you r in this @ all! until later
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 18 at 12:35 AM
$BOLT i may have a new change of plans for your future. Will be in touch
0 · Reply
rp6577
rp6577 Jul. 10 at 2:52 PM
$BOLT heating up
0 · Reply
TwongStocks
TwongStocks Jul. 9 at 10:43 PM
One month post-RS recap. $HUSA 1:10 RS on Jun 9, closed $4.39 Like NKTR, also found success since the RS. On Jun 13, they issued a PR due to "unusual trading activity" in its stock. Jun 13 volume was 28.8m despite no major news. Hit a high of $25.56 on Jun 23. Has gone down since, but is still trading above its close on Jun 9. Today closed $9.99 , up 127.56% from RS close. $PXLW 1:12 RS on Jun 9, closed $5.84 After hitting a low of $4.67 on Jun 12, managed to hit a post-RS high of $10.10 on Jun 20. Today closed $7.16, up 22.6% from RS close. $BOLT 1:20 RS on Jun 9, closed $6.14 Reached a high of $7.35 on Jun 10. Today closed $6.22, up 1.30% from RS close.
0 · Reply
rp6577
rp6577 Jul. 9 at 2:02 PM
$BOLT partnership news soon
0 · Reply
SugarPumping
SugarPumping Jul. 2 at 4:15 AM
$BOLT watch out todays premarket, chart looks like ready to gap up
0 · Reply